Article
Tumor-secreted versican co-opts myeloid IKKβ during metastasis
2021-05-22
Abstract excerpt
The mechanisms tumor cells use to hijack the immune system are largely uncharted. Here we used bioluminescent nuclear factor (NF)-κB reporter mice and macrophages to discover that metastatic tumors trigger NF-κB activation in host macrophages, dependent on mutant KRAS signaling and delivered via secretory versican. Versican activates NF-κB in tumor-associated macrophages via inhibitor of NF-κB kinase (IKK) β, res...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c230ae8d-ff39-5e60-95ee-6b070b2ec79e
- DOI
- 10.1101/2021.05.20.444963
